Report Categories
View AllRecent Articles
View All
LRMR Larimar Therapeutics Q4 loss widens 41 miss as drug development costs climb shares edge lower
American Express AXP Strategic Delta Partnership Yields 9 Billion CoBrand Revenue Milestone
OMDA Omada Health Inc far outpaces Q4 2025 earnings expectations shares rise 576 percent on positive investor sentiment